Transaction notification
1. Details of PDMR/person closely associated with them (‘PCA’) a)Name Emma Walmsley b) Position/status Chief Executive Officer Initial notification/ c) Initial notification amendment 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)Name GSK plc b) LEI 5493000HZTVUYLO1D793 Details of the transaction(s): section to be repeated for (i) each type of 3. instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted Description of the Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) a) financial instrument ISIN: GB00BN7SWP63 b) Nature of the Acquisition of Ordinary Shares under the Company’s transaction Share Reward Plan Price(s) Volume(s) c) Price(s) and volume(s) £14.9465 9 (partnership shares) £14.9465 9 (matching shares) Aggregated information d) Aggregated volume 18 Ordinary Shares Price £14.9465 e) Date of the 2025-06-10 transaction f) Place of theLondon Stock Exchange (XLON) transaction
1. Details of PDMR/person closely associated with them (‘PCA’) a)Name Julie Brown b) Position/status Chief Financial Officer Initial notification/ c) Initial notification amendment 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)Name GSK plc b) LEI 5493000HZTVUYLO1D793 Details of the transaction(s): section to be repeated for (i) each type of 3. instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted Description of the Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) a) financial instrument ISIN: GB00BN7SWP63 b) Nature of the Acquisition of Ordinary Shares under the Company’s transaction Share Reward Plan Price(s) Volume(s) c) Price(s) and volume(s) £14.9465 8 (partnership shares) £14.9465 8 (matching shares) Aggregated information d) Aggregated volume 16 Ordinary Shares Price £14.9465 e) Date of the 2025-06-10 transaction f) Place of theLondon Stock Exchange (XLON) transaction
1. Details of PDMR/person closely associated with them (‘PCA’) a)Name James Ford b) Position/statusSVP and Group General Counsel, Legal and Compliance Initial notification/ c) Initial notification amendment 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)Name GSK plc b) LEI 5493000HZTVUYLO1D793 Details of the transaction(s): section to be repeated for (i) each type of 3. instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted Description of the Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) a) financial instrument ISIN: GB00BN7SWP63 b) Nature of the Acquisition of Ordinary Shares under the Company’s transaction Share Reward Plan Price(s) Volume(s) c) Price(s) and volume(s) £14.9465 8 (partnership shares) £14.9465 8 (matching shares) Aggregated information d) Aggregated volume 16 Ordinary Shares Price £14.9465 e) Date of the 2025-06-10 transaction f) Place of theLondon Stock Exchange (XLON) transaction
1. Details of PDMR/person closely associated with them (‘PCA’) a)Name Sally Jackson b) Position/status SVP,Global Communications and CEO Office Initial notification/ c) Initial notification amendment 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)Name GSK plc b) LEI 5493000HZTVUYLO1D793 Details of the transaction(s): section to be repeated for (i) each type of 3. instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted Description of the Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) a) financial instrument ISIN: GB00BN7SWP63 b) Nature of the Acquisition of Ordinary Shares under the Company’s transaction Share Reward Plan Price(s) Volume(s) c) Price(s) and volume(s) £14.9465 8 (partnership shares) £14.9465 8 (matching shares) Aggregated information d) Aggregated volume 16 Ordinary Shares Price £14.9465 e) Date of the 2025-06-10 transaction f) Place of theLondon Stock Exchange (XLON) transaction
1. Details of PDMR/person closely associated with them (‘PCA’) a)Name David Redfern b) Position/status President, Corporate Development Initial notification/ c) Initial notification amendment 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)Name GSK plc b) LEI 5493000HZTVUYLO1D793 Details of the transaction(s): section to be repeated for (i) each type of 3. instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted Description of the Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) a) financial instrument ISIN: GB00BN7SWP63 b) Nature of the Acquisition of Ordinary Shares under the Company’s transaction Share Reward Plan Price(s) Volume(s) c) Price(s) and volume(s) £14.9465 8 (partnership shares) £14.9465 8 (matching shares) Aggregated information d) Aggregated volume 16 Ordinary Shares Price £14.9465 e) Date of the 2025-06-10 transaction f) Place of theLondon Stock Exchange (XLON) transaction
1. Details of PDMR/person closely associated with them (‘PCA’) a)Name Regis Simard b) Position/status President, Global Supply Chain Initial notification/ c) Initial notification amendment 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)Name GSK plc b) LEI 5493000HZTVUYLO1D793 Details of the transaction(s): section to be repeated for (i) each type of 3. instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted Description of the Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) a) financial instrument ISIN: GB00BN7SWP63 b) Nature of the Acquisition of Ordinary Shares under the Company’s transaction Share Reward Plan Price(s) Volume(s) c) Price(s) and volume(s) £14.9465 8 (partnership shares) £14.9465 8 (matching shares) Aggregated information d) Aggregated volume 16 Ordinary Shares Price £14.9465 e) Date of the 2025-06-10 transaction f) Place of theLondon Stock Exchange (XLON) transaction
1. Details of PDMR/person closely associated with them (‘PCA’) a)Name Philip Thomson b) Position/status President, Global Affairs Initial notification/ c) Initial notification amendment 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)Name GSK plc b) LEI 5493000HZTVUYLO1D793 Details of the transaction(s): section to be repeated for (i) each type of 3. instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted Description of the Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) a) financial instrument ISIN: GB00BN7SWP63 b) Nature of the Acquisition of Ordinary Shares under the Company’s transaction Share Reward Plan Price(s) Volume(s) c) Price(s) and volume(s) £14.9465 8 (partnership shares) £14.9465 8 (matching shares) Aggregated information d) Aggregated volume 16 Ordinary Shares Price £14.9465 e) Date of the 2025-06-10 transaction f) Place of theLondon Stock Exchange (XLON) transaction
1. Details of PDMR/person closely associated with them (‘PCA’) a)Name Deborah Waterhouse b) Position/status CEO,ViiV Healthcare and President, Global Health, GSK Initial notification/ c) Initial notification amendment 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)Name GSK plc b) LEI 5493000HZTVUYLO1D793 Details of the transaction(s): section to be repeated for (i) each type of 3. instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted Description of the Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) a) financial instrument ISIN: GB00BN7SWP63 b) Nature of the Acquisition of Ordinary Shares under the Company’s transaction Share Reward Plan Price(s) Volume(s) c) Price(s) and volume(s) £14.9465 8 (partnership shares) £14.9465 8 (matching shares) Aggregated information d) Aggregated volume 16 Ordinary Shares Price £14.9465 e) Date of the 2025-06-10 transaction f) Place of theLondon Stock Exchange (XLON) transaction
1. Details of PDMR/person closely associated with them (‘PCA’) a)Name Victoria Whyte b) Position/status Company Secretary Initial notification/ c) Initial notification amendment 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)Name GSK plc b) LEI 5493000HZTVUYLO1D793 Details of the transaction(s): section to be repeated for (i) each type of 3. instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted Description of the Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) a) financial instrument ISIN: GB00BN7SWP63 b) Nature of the Acquisition of Ordinary Shares under the Company’s transaction Share Reward Plan Price(s) Volume(s) c) Price(s) and volume(s) £14.9465 8 (partnership shares) £14.9465 8 (matching shares) Aggregated information d) Aggregated volume 16 Ordinary Shares Price £14.9465 e) Date of the 2025-06-10 transaction f) Place of theLondon Stock Exchange (XLON) transaction
